Retour
Prix Ascentage Pharma Group International (ASPHF)
Graphique du cours de l'action ASPHF
ASPHF Gagner
Ascentage Pharma Group International
$8.48
0%
$0
À la fermeture : Jan 23, 16:00:00 GMT-5
$8.48
0%
$0
Post-Marché: Jan 23, 20:00:00 GMT-5
Statistiques clés
Clôture préc.
$8.48
Prix d'ouverture
$8.48
Plage de la journée
$8.48 - $8.48
Plage de 52 semaines
$5.42 - $10.65
Volume
100
Volume moyen
58
BPA (TTM)
-0.52
Rendement en dividend
--
Capitalisation boursière
$3.1B
Qu’est-ce que ASCENTAGE PHARMA GROUP INTL ?
Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. The company is headquartered in Suzhou, Jiangsu and currently employs 605 full-time employees. The company went IPO on 2019-10-28. The firm's main products include Olverembatinib (HQP1351), Lisaftoclax (APG-2575), Alrizomadlin (APG-115), Pelcitoclax (APG-1252), APG-5918, and APG-2449. The firm's products are primarily used to treat chronic myeloid leukemia (CML), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS) and multiple myeloma (MM). The firm primarily conducts its businesses in domestic market.
Fonctionnalités
Stratégies de trading
Ressources
© 2025 Finture Development Limited. All rights reserved